These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34856338)

  • 1. Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD.
    Ruzieh M; Baugh AD; Al Jebbawi L; Edwards ES; Jia KQ; Dransfield MT; Foy AJ
    Trends Cardiovasc Med; 2023 Jan; 33(1):53-61. PubMed ID: 34856338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Quint JK
    BMJ Open; 2018 Nov; 8(11):e024736. PubMed ID: 30429149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in COPD: A systematic review based on recent research.
    Li XF; Mao YM
    Life Sci; 2020 Jul; 252():117649. PubMed ID: 32275936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Alderman V; Morgan A; Ross J; Quint JK
    Respir Res; 2021 Feb; 22(1):64. PubMed ID: 33622362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
    Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
    Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
    Suissa S; Ernst P
    COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.
    Baou K; Katsi V; Makris T; Tousoulis D
    Curr Hypertens Rev; 2021; 17(3):196-206. PubMed ID: 33302840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
    Chapman KR; Wise RA; Scirica BM; Bhatt DL; Daoud SZ; Lythgoe D; Gil EG
    Respir Res; 2021 Oct; 22(1):272. PubMed ID: 34686204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
    Minor DS; Meyer AM; Long RC; Butler KR
    J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocker under-use in COPD patients.
    Lim KP; Loughrey S; Musk M; Lavender M; Wrobel JP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3041-3046. PubMed ID: 29089752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
    Wade C; Wells JM
    Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.